RYZUMVI
Live / Applied — Fourth extension granted (statement of use) (as of 30 Jan 2026)
What this means for you
Not registered yet, but its 10 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97626126
- Mark type
- Stylized text
- Filed
- 10 Oct 2022
- Published for opposition
- 05 Dec 2023
- Attorney of record
- Jennifer Insley-Pruitt
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- OPUS GENETICS, INC., DURHAM, NC, US
- OCUPHIRE PHARMA, INC., Farmington Hills, MI, US
- OCUPHIRE PHARMA, INC., Farmington Hills, MI, US
Prosecution history
- 31 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2026 — SOU EXTENSION 4 GRANTED
- 29 Jan 2026 — SOU EXTENSION 4 FILED
- 29 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2025 — SOU EXTENSION 3 GRANTED
- 22 Jul 2025 — SOU EXTENSION 3 FILED
- 23 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2025 — SOU EXTENSION 2 GRANTED